1. Home
  2. EVAX vs JFU Comparison

EVAX vs JFU Comparison

Compare EVAX & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • JFU
  • Stock Information
  • Founded
  • EVAX 2008
  • JFU 2006
  • Country
  • EVAX Denmark
  • JFU China
  • Employees
  • EVAX N/A
  • JFU N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • JFU Finance: Consumer Services
  • Sector
  • EVAX Health Care
  • JFU Finance
  • Exchange
  • EVAX Nasdaq
  • JFU Nasdaq
  • Market Cap
  • EVAX 17.8M
  • JFU 17.1M
  • IPO Year
  • EVAX 2021
  • JFU 2019
  • Fundamental
  • Price
  • EVAX $2.95
  • JFU $2.57
  • Analyst Decision
  • EVAX Strong Buy
  • JFU
  • Analyst Count
  • EVAX 2
  • JFU 0
  • Target Price
  • EVAX $10.00
  • JFU N/A
  • AVG Volume (30 Days)
  • EVAX 68.5K
  • JFU 20.0K
  • Earning Date
  • EVAX 10-30-2025
  • JFU 01-01-0001
  • Dividend Yield
  • EVAX N/A
  • JFU N/A
  • EPS Growth
  • EVAX N/A
  • JFU N/A
  • EPS
  • EVAX N/A
  • JFU 0.58
  • Revenue
  • EVAX $3,176,000.00
  • JFU $42,467,427.00
  • Revenue This Year
  • EVAX N/A
  • JFU N/A
  • Revenue Next Year
  • EVAX $425.50
  • JFU N/A
  • P/E Ratio
  • EVAX N/A
  • JFU $4.50
  • Revenue Growth
  • EVAX 1042.45
  • JFU N/A
  • 52 Week Low
  • EVAX $1.20
  • JFU $1.01
  • 52 Week High
  • EVAX $16.69
  • JFU $3.60
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 52.92
  • JFU 61.58
  • Support Level
  • EVAX $2.81
  • JFU $2.51
  • Resistance Level
  • EVAX $3.04
  • JFU $2.80
  • Average True Range (ATR)
  • EVAX 0.22
  • JFU 0.16
  • MACD
  • EVAX -0.00
  • JFU -0.01
  • Stochastic Oscillator
  • EVAX 69.35
  • JFU 53.06

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.

Share on Social Networks: